We serve Chemical Name:3,4-Difluoro-2-methylbenzonitrile CAS:847502-83-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,4-Difluoro-2-methylbenzonitrile
CAS.NO:847502-83-4
Synonyms:Benzonitrile, 3,4-difluoro-2-methyl-;3,4-Difluoro-o-tolunitrile;NCR CF DF B1;3,4-Difluoro-2-methylbenzonitrile
Molecular Formula:C8H5F2N
Molecular Weight:153.129
HS Code:2926909090
Physical and Chemical Properties:
Melting point:39-44℃
Boiling point:213.5±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.487
PSA:23.79000
Exact Mass:153.039001
LogP:1.88
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzonitrile, 3,4-difluoro-2-methyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-Difluoro-2-methylbenzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,NCR CF DF B1 Use and application,3,4-Difluoro-2-methylbenzonitrile technical grade,usp/ep/jp grade.
Related News: Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. 1H-Pyrazole-4-carbonitrile, 1-methyl-5-(methylthio)-3-phenyl- manufacturers Elliott made its intention for a C-suite overhaul clear in an open letter early July. The activist investor called on GSK to appoint a new board directors with biopharma and consumer health expertise to select the leaders for the two companies. (S)-1-[(2S,3S,5R)-3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-diphenyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-2-methyl-hept-6-en-3-ol suppliers AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added. Hydrolase, cyanate (Synechococcus strain PCC7942 gene cynS) vendor & factory.
